Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
START Trial in primary knee osteoarthritis
RBR-7qjcddPhase 3Recruiting
- Sponsor
- Prevent Senior
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes, Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of platelet-rich plasma, mesenchymal stem cells, autologous bone marrow cell concentrate and sodium hyaluronate in knee osteoarthritis (OA) (4 arms), sponsored by Prevent Senior. Started Jan 2019; status: recruiting.
02
Drugs
platelet-rich plasmamesenchymal stem cellsautologous bone marrow cell concentratesodium hyaluronate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on RBR-7qjcdd.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7qjcdd.